ARCHIVES

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

ACS Concludes That Laetrile Organization Is Insignificant

November 29, 1991

Schmidt Already Working For NIH Despite His Opposition To Kennedy’s New Research Panel

April 12, 1974

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012

Guest Editorial “Gizmo Idolatry” and Marketing Da Vinci’s Radical Robot

September 26, 2014

AIDS Cachexia Drug Stabilizes Body Weight, Muscle Mass

March 29, 2013

In Brief: Jay Moskowitz Reassigned; Healy To Run For Ohio Republican Nomination To Senate

September 17, 1993